Neutrophil infiltration and NET formation impede therapeutic thrombolysis in stroke patients, which led to anti-NET approaches including DNase I in clinical trial as an adjuvant in tPA-mediated thrombolysis. This evidence concerns the gene PLAT and stroke disorder.